Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/EP2017/084602, filed Dec 27, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,345,662 | Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides In force · High confidence UsedRemaining | Ucb Pharma GmbH | In force | High confidence | ||
| US 11,820,746 | Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides In force · High confidence | Ucb Pharma GmbH | In force | High confidence | ||
| US 12,071,404 | Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides In force · High confidence | Ucb Pharma GmbH | In force | High confidence | ||
| Application 18/219,417 | Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides Abandoned Abandoned Jun 12, 2026 | Ucb Pharma GmbH | Abandoned | Abandoned Jun 12, 2026 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.